CHI3L1 and early-onset autosomal dominant Alzheimer disease: Furthermore, YKL-40 is physiologically expressed in activated microglia and astrocytes, making it a potential diagnostic biomarker for neurological disorders as hypothesized for patients with Alzheimer’s disease (67).